Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trial (vol 17, pg 342, 2023)

被引：0
|
作者：
Witztum, Joseph L. [1 ]
Gaudet, Daniel [2 ,3 ]
Arca, Marcello [4 ]
Jones, Alan [5 ]
Soran, Handrean [6 ]
Gouni-Berthold, Ioanna [7 ,8 ]
Stroes, Erik S. G. [9 ]
Alexander, Veronica J. [10 ]
Jones, Richard [11 ]
Watts, Lynnetta [10 ]
Xia, Shuting [10 ]
Tsimikas, Sotirios [1 ,10 ]
机构：
[1] Univ Calif San Diego, Dept Med, Room 1081,9500 Gilman Dr, La Jolla, CA 92093 USA
[2] Univ Montreal, Community Genom Med Ctr, Dept Med, Lipidol Unit, 930 Jacques Cartier Est, Chicoutimi, PQ G7H 7K9, Canada
[3] ECOGENE 21, 930 Jacques Cartier Est, Chicoutimi, PQ G7H 7K9, Canada
[4] Univ Roma La Sapienza, Dept Translat & Precis Med, Viale Univ 37, I-00185 Rome, Italy
[5] Univ Hosp Birmingham NHS Fdn Trust, Heartlands Hosp, Bordesley Green E, Birmingham B9 5SS, England
[6] Manchester Univ NHS Fdn Trust, Manchester Royal Infirm, Oxford Rd, Manchester M13 9WL, England
[7] Univ Cologne, Fac Med, Ctr Endocrinol Diabet & Prevent Med, Kerpener Str 62, D-50937 Cologne, Germany
[8] Univ Hosp Cologne, Kerpener Str 62, D-50937 Cologne, Germany
[9] Acad Med Ctr, Dept Vasc Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands
[10] Ionis Pharmaceut, 2855 Gazelle Court, Carlsbad, CA 92010 USA
[11] Akcea Therapeut, St James House,72 Adelaide Rd 2, Dublin D02 Y017, Ireland
来源：
JOURNAL OF CLINICAL LIPIDOLOGY | 2024年 / 18卷 / 03期
关键词：
D O I：
10.1016/j.jacl.2023.09.010
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：e482 / e483
页数：2
相关论文
共 50 条
  • [41] INTERIM LONG-TERM SAFETY/EFFICACY OF RISANKIZUMAB TREATMENT IN CROHN'S DISEASE PATIENTS FROM THE OPEN-LABEL EXTENSION STUDY
    Ferrante, M.
    Panes, J.
    Baert, F.
    Louis, E.
    Kaser, A.
    Gustafson, D.
    Hall, D.
    Boecher, W. O.
    Herichova, I.
    Liao, X.
    Wallace, K.
    Kalabic, J.
    D'Haens, G.
    GUT, 2019, 68 : A64 - A64
  • [42] Long-term Safety and Efficacy of Add-on Cannabidiol (CBD) Treatment in Patients with Lennox Gastaut Syndrome in an Open-label Extension Trial (GWPCARE5)
    Patel, Anup
    Gil-Nagel, Antonio
    Chin, Richard
    Mitchell, Wendy
    Perry, M. Scott
    Weinstock, Arie
    Roberts, Claire
    Whyte, Lauren
    VanLandingham, Kevan
    NEUROLOGY, 2019, 92 (15)
  • [43] Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS Study
    Vermeire, Severine
    Chiorean, Michael
    Panes, Julian
    Peyrin-Biroulet, Laurent
    Zhang, Jinkun
    Sands, Bruce E.
    Lazin, Krisztina
    Klassen, Preston
    Naik, Snehal U.
    Cabell, Christopher H.
    Sandborn, William J.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 (06): : 950 - 959
  • [44] Long-Term Safety and Efficacy of Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from the CLEAR Harmony Open-Label Extension Study)
    Ballantyne, Christie M.
    Banach, Maciej
    Bays, Harold E.
    Catapano, Alberico L.
    Laufs, Ulrich
    Stroes, Erik S. G.
    Robinson, Paula
    Lei, Lei
    Ray, Kausik K.
    AMERICAN JOURNAL OF CARDIOLOGY, 2022, 174 : 1 - 11
  • [45] Long-term efficacy and safety of continuous q12w risankizumab: Results from the open-label extension LIMMitless trial
    Papp, Kim
    Lebwohl, Mark
    Puig, Luis
    Zeng, Jiewei
    Rubant, Simone
    Valdes, Joaquin
    Leonardi, Craig
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB17 - AB17
  • [46] Long-term safety and tolerability of iloperidone: results from a 25-week, open-label extension trial
    Cutler, Andrew J.
    Kalali, Amir H.
    Mattingly, Greg W.
    Kunovac, Jelena
    Meng, Xiangyi
    CNS SPECTRUMS, 2013, 18 (01) : 43 - 54
  • [47] Open-label assessment of the long-term tolerability, safety, and efficacy of sertindole in patients with schizophrenia
    Hale, T.
    Murray, R. M.
    Azorin, J. M.
    Maehlum, E.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 431 - 432
  • [48] Open-label assessment of the long-term tolerability, safety, and efficacy of sertindole in patients with schizophrenia
    Hale, A.
    Murray, R. M.
    Azorin, J. M.
    Maehium, E.
    EUROPEAN PSYCHIATRY, 2007, 22 : S113 - S113
  • [49] Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study
    Wechsler, Michael E.
    Ford, Linda B.
    Maspero, Jorge F.
    Pavord, Ian D.
    Papi, Alberto
    Bourdin, Arnaud
    Watz, Henrik
    Castro, Mario
    Nenasheva, Natalia M.
    Tohda, Yuji
    Langton, David
    Cardona, Guido
    Domingo, Christian
    Park, Hae Sim
    Chapman, Kenneth R.
    Mao, Xuezhou
    Zhang, Yi
    Khan, Asif H.
    Deniz, Yamo
    Rowe, Paul J.
    Kapoor, Upender
    Khokhar, Faisal A.
    Mannent, Leda P.
    Ruddy, Marcella
    Laws, Elizabeth
    Amin, Nikhil
    Hardin, Megan
    LANCET RESPIRATORY MEDICINE, 2022, 10 (01): : 11 - 25
  • [50] Long-Term Safety, Tolerability and Efficacy of Flexible-Dose Fesoterodine in Elderly Patients With Overactive Bladder: Open-Label Extension of the SOFIA Trial
    Wagg, Adrian
    Khullar, Vik
    Michel, Martin C.
    Oelke, Matthias
    Darekar, Amanda
    Bitoun, Caty Ebel
    NEUROUROLOGY AND URODYNAMICS, 2014, 33 (01) : 106 - 114
12345